Unveiling Three US Growth Companies With High Insider Ownership

Amid a backdrop of rising markets with the Dow Jones Industrial Average reaching new heights, the U.S. stock market continues to display resilience and optimism. In such an environment, growth companies with high insider ownership can offer intriguing opportunities, as aligned interests between shareholders and management often bode well for long-term performance.

Top 10 Growth Companies With High Insider Ownership In The United States

Name	Insider Ownership	Earnings Growth
PDD Holdings (NasdaqGS:PDD)	32.1%	23.3%
Atour Lifestyle Holdings (NasdaqGS:ATAT)	26%	22.1%
GigaCloud Technology (NasdaqGM:GCT)	25.9%	21.3%
Victory Capital Holdings (NasdaqGS:VCTR)	12%	33.6%
Bridge Investment Group Holdings (NYSE:BRDG)	11.6%	98.2%
Super Micro Computer (NasdaqGS:SMCI)	14.3%	40.1%
Credo Technology Group Holding (NasdaqGS:CRDO)	14.7%	60.9%
Carlyle Group (NasdaqGS:CG)	29.2%	23.6%
EHang Holdings (NasdaqGM:EH)	32.8%	74.3%
BBB Foods (NYSE:TBBB)	22.9%	94.7%

Click here to see the full list of 181 stocks from our Fast Growing US Companies With High Insider Ownership screener.

Let's uncover some gems from our specialized screener.

Krystal Biotech (NasdaqGS:KRYS)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Krystal Biotech, Inc. is a commercial-stage biotechnology company based in the United States, focusing on the discovery, development, and commercialization of genetic medicines for rare diseases, with a market capitalization of approximately $5.80 billion.

Operations: The company focuses on genetic medicines for rare diseases and does not report specific revenue segments.

Insider Ownership: 10.7%

Revenue Growth Forecast: 34.1% p.a.

Krystal Biotech, recently added to several S&P indices, shows a robust growth trajectory with forecasted earnings and revenue growth significantly outpacing the market. Despite recent profitability and high insider ownership underscoring strong leadership confidence, challenges include shareholder dilution over the past year. The firm's strategic presentations across major healthcare conferences and advancements in clinical trials highlight its active role in biotech innovation, particularly in cancer treatment through novel gene therapies.

• Click here to discover the nuances of Krystal Biotech with our detailed analytical future growth report.
• In light of our recent valuation report, it seems possible that Krystal Biotech is trading beyond its estimated value.

VSE (NasdaqGS:VSEC)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: VSE Corporation, operating in the United States, is a diversified aftermarket products and services company with a market capitalization of approximately $1.64 billion.

Operations: The company generates revenue primarily through two segments: Fleet, which contributes $320.27 million, and Aviation, accounting for $593.17 million.

Insider Ownership: 12.7%

Revenue Growth Forecast: 12.8% p.a.

VSE, recently included in multiple Russell indices, is poised for substantial growth with earnings expected to rise 33.12% annually and revenue forecasted to increase at 12.8% per year, outperforming the US market average. Despite this promising outlook, challenges like shareholder dilution and insufficient coverage of interest payments by earnings temper its financial position. The firm's active participation in industry conferences underscores its commitment to maintaining visibility and relevance in the sector.

• Click here and access our complete growth analysis report to understand the dynamics of VSE.
• Our expertly prepared valuation report VSE implies its share price may be too high.

Zeta Global Holdings (NYSE:ZETA)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Zeta Global Holdings Corp. operates an omnichannel data-driven cloud platform, offering consumer intelligence and marketing automation software globally, with a market capitalization of approximately $3.86 billion.

Operations: The company generates its revenue primarily from Internet Software & Services, totaling approximately $766.07 million.

Insider Ownership: 17%

Revenue Growth Forecast: 16.2% p.a.

Zeta Global Holdings, while not top in its class for growth companies with high insider ownership, shows a promising financial trajectory. Expected to become profitable within three years, Zeta's revenue growth at 16.2% annually outpaces the US market average of 8.7%. The company's return on equity is projected to be very high at 47.8% in three years. However, shareholder dilution over the past year and a trading value 13% below estimated fair value present challenges. Recent partnerships and board enhancements signal strategic expansion and governance strengthening.

• Take a closer look at Zeta Global Holdings' potential here in our earnings growth report.
• Insights from our recent valuation report point to the potential overvaluation of Zeta Global Holdings shares in the market.

Turning Ideas Into Actions

• Reveal the 181 hidden gems among our Fast Growing US Companies With High Insider Ownership screener with a single click here.
• Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
• Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Interested In Other Possibilities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com